F106L (p.Phe106Leu) variant of AGT (Angiotensinogen)
F106L (p.Phe106Leu) in AGT (Angiotensinogen) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
F106L (p.Phe106Leu) variant details
- p.Phe106Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available